DiDonato C - Search Results

1

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.

Glascock J, Darras BT, Crawford TO, Sumner CJ, Kolb SJ, DiDonato C, Elsheikh B, Howell K, Farwell W, Valente M, Petrillo M, Tingey J, Jarecki J. Glascock J, et al. Among authors: didonato c. J Neuromuscul Dis. 2023;10(5):937-954. doi: 10.3233/JND-230054. J Neuromuscul Dis. 2023. PMID: 37458045 Free PMC article.

2

Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future.

McGrattan KE, Graham RJ, DiDonato CJ, Darras BT. McGrattan KE, et al. Among authors: didonato cj. Am J Speech Lang Pathol. 2021 May 18;30(3):1008-1022. doi: 10.1044/2021_AJSLP-20-00217. Epub 2021 Apr 6. Am J Speech Lang Pathol. 2021. PMID: 33822657 Free PMC article. Review.

3

Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.

Gavrilina TO, McGovern VL, Workman E, Crawford TO, Gogliotti RG, DiDonato CJ, Monani UR, Morris GE, Burghes AH. Gavrilina TO, et al. Hum Mol Genet. 2008 Apr 15;17(8):1063-75. doi: 10.1093/hmg/ddm379. Epub 2008 Jan 4. Hum Mol Genet. 2008. PMID: 18178576 Free PMC article.

4

A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients.

Thompson TG, DiDonato CJ, Simard LR, Ingraham SE, Burghes AH, Crawford TO, Rochette C, Mendell JR, Wasmuth JJ. Thompson TG, et al. Among authors: didonato cj. Nat Genet. 1995 Jan;9(1):56-62. doi: 10.1038/ng0195-56. Nat Genet. 1995. PMID: 7704025

5

In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.

Ojala KS, Reedich EJ, DiDonato CJ, Meriney SD. Ojala KS, et al. Among authors: didonato cj. Brain Sci. 2021 Feb 5;11(2):194. doi: 10.3390/brainsci11020194. Brain Sci. 2021. PMID: 33562482 Free PMC article. Review.

6

Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity?

DiDonato CJ, Ingraham SE, Mendell JR, Prior TW, Lenard S, Moxley RT 3rd, Florence J, Burghes AH. DiDonato CJ, et al. Ann Neurol. 1997 Feb;41(2):230-7. doi: 10.1002/ana.410410214. Ann Neurol. 1997. PMID: 9029072

7

A short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophy.

Keil JM, Seo J, Howell MD, Hsu WH, Singh RN, DiDonato CJ. Keil JM, et al. Mol Ther Nucleic Acids. 2014 Jul 8;3(7):e174. doi: 10.1038/mtna.2014.23. Mol Ther Nucleic Acids. 2014. PMID: 25004100 Free PMC article.

8

Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Singh NN, Lee BM, DiDonato CJ, Singh RN. Singh NN, et al. Future Med Chem. 2015;7(13):1793-808. doi: 10.4155/fmc.15.101. Epub 2015 Sep 18. Future Med Chem. 2015. PMID: 26381381 Free PMC article. Review.

9

Combination molecular therapies for type 1 spinal muscular atrophy.

Harada Y, Rao VK, Arya K, Kuntz NL, DiDonato CJ, Napchan-Pomerantz G, Agarwal A, Stefans V, Katsuno M, Veerapandiyan A. Harada Y, et al. Among authors: didonato cj. Muscle Nerve. 2020 Oct;62(4):550-554. doi: 10.1002/mus.27034. Epub 2020 Aug 10. Muscle Nerve. 2020. PMID: 32710634

10

A multicopy dinucleotide marker that maps close to the spinal muscular atrophy gene.

Burghes AH, Ingraham SE, McLean M, Thompson TG, McPherson JD, Kote-Jarai Z, Carpten JD, DiDonato CJ, Ikeda JE, Surh L, et al. Burghes AH, et al. Among authors: didonato cj. Genomics. 1994 May 15;21(2):394-402. doi: 10.1006/geno.1994.1282. Genomics. 1994. PMID: 8088834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page